Medscape is available in 5 Language Editions – Choose your Edition here.


Hydronephrosis and Hydroureter Treatment & Management

  • Author: Dennis G Lusaya, MD; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
Updated: Jul 18, 2016

Medical Care

The role of medical treatment of hydronephrosis and hydroureter in adults is limited to pain control and treatment or prevention of infection. Most conditions require either minimally invasive or open surgical treatment. Two notable exceptions are (1) oral alkalinization therapy for uric acid stones and (2) steroid therapy for retroperitoneal fibrosis.

The management approach to infants with antenatal hydronephrosis is based on the confirmation of persistent postnatal hydronephrosis and the following two predictive factors:

  • Bilateral involvement
  • Severe hydronephrosis: Fetuses with a renal pelvic diameter greater than 15 mm during the third trimester are at the greatest risk for significant renal disease

Bilateral hydronephrosis

Infants with severe bilateral antenatal hydronephrosis and/or bladder distension are at increased likelihood of having significant disease. These infants and those with a severe hydronephrotic solitary kidney should be evaluated initially by ultrasonography on the first postnatal day. Bilateral hydronephrosis suggests an obstructive process at the level of or distal to the bladder, such as ureterocele or posterior urethral valves (PUV) in a male infant, which can be associated with impaired renal function and ongoing renal injury.

If postnatal ultrasonography demonstrates persistent hydronephrosis, voiding cystourethrography (VCUG) should be performed. In male infants, the posterior urethra should be fully evaluated to detect possible PUVs.

Infants with mild or moderate hydronephrosis can be evaluated after 7 days of life.

Severe unilateral hydronephrosis

In newborns with severe antenatal unilateral hydronephrosis (renal pelvic diameter >15 mm in the third trimester), ultrasonography should be performed after the infant returns to birth weight (after age 48 h and within the first 2 wk of life).

Moderate and mild unilateral hydronephrosis

In newborns with less severe antenatal unilateral hydronephrosis (renal pelvic diameter < 15 mm during third trimester), ultrasonography can be performed after age 7 days to see whether the hydronephrosis has persisted postnatally.

Moderate hydronephrosis resolves by age 18 months in most cases. This was illustrated by a prospective study of 282 infants (age 2 mo) with renal pelvic diameters between 10 and 15 mm, which resolved in 94% of patients by age 12-14 months (resolution was defined as renal pelvic diameter ≤5 mm on two consecutive ultrasounds). Of the 18 patients with persistent hydronephrosis, 14 had ureteropelvic junction (UPJ) obstruction and 4 had vesicoureteral reflux (VUR).[27]

Antibiotic prophylaxis

Higher rates of urinary tract infections have been reported in children with prenatally diagnosed hydronephrosis compared with the general pediatric population.[28, 29] The risk of infection rises if there is an underlying urologic abnormality, such as VUR or obstructive uropathy, and is greater in girls compared with boys.[30]

As a result, in infants with severe hydronephrosis who are at greater risk for an underlying urologic abnormality, antibiotic prophylaxis is started after delivery until the diagnosis of VUR or obstructive uropathy is excluded.

Antibiotic prophylaxis in children with mild or moderate hydronephrosis confirmed postnatally has not been studied prospectively. In one retrospective study of 1514 with mild persistent hydronephrosis, the use of prophylactic antibiotics reduced the risk of febrile urinary tract infection in patients who had VUR.[31] Until further prospective studies are conducted, antibiotic prophylaxis should be considered until VCUG has been performed and either the diagnosis of VUR has been made or eliminated.

Antibiotic prophylaxis is not needed in infants with normal postnatal ultrasonography findings.[32]

Three recent retrospective studies have considered the role of antibiotic prophylaxis in infants with hydronephrosis. Zareba et al analyzed the risk factors for urinary tract infection (UTI) in 376 infants with prenatal hydronephrosis and reported that infants with high-grade hydronephrosis, girls, and uncircumcised boys were at highest risk for UTI. Antibiotic prophylaxis did not decrease the risk in any of the groups studied.[33]

In a systematic review that included 3876 newborns with antenatal hydronephrosis, Braga et al found that infants with high-grade hydronephrosis receiving continuous antibiotic prophylaxis (CAP) had significantly lower UTI rates than those who did not receive an antibiotic regimen (14.6% vs 28.9%). However, the rates for infants with low-grade hydronephrosis were similar (2.2% vs. 2.8%). The researchers cautioned that the level of evidence of available data was moderate to low.[34]

Herz et al reviewed the records of 278 children maintained on CAP and 127 who were not and compared individual characteristics to determine risk factors for UTI. The presence of ureteral dilation, high-grade VUR, and ureterovesical junction obstruction were independent risk factors for development of UTI. CAP had a significant role in reducing UTI in children with the risk factors but was unnecessary otherwise.[35]


Surgical Care

The specific treatment of a patient with hydronephrosis and hydroureter depends, of course, on the etiology of the process. Several factors help determine the urgency with which treatment should be initiated. In general, any signs of infection within the obstructed system warrant urgent intervention because infection with hydronephrosis may progress rapidly to sepsis. A mildly elevated white blood cell count is often observed in patients with stones but does not necessarily mandate immediate action in the absence of other signs or symptoms of systemic infection. However, even a low-grade fever in a diabetic or immunosuppressed patient (ie, on steroid therapy) requires immediate treatment.

The potential for loss of renal function also adds to the urgency (eg, hydronephrosis or hydroureter bilaterally or in a solitary kidney). Finally, patient symptoms help determine the urgency with which treatment is initiated. For example, refractory pain in a patient with an obstructing ureteral calculus necessitates intervention, as does intractable nausea and vomiting.

Urethral catheterization is important to help rule out a lower tract cause for hydronephrosis and hydroureter. Difficulty in placing a Foley catheter may suggest urethral stricture or bladder neck contracture.

Urologists commonly use ureteral stent placement in cases of intrinsic and extrinsic causes of hydronephrosis. The procedure is usually performed in conjunction with cystoscopy and retrograde pyelography. Stents can bypass an obstruction and dilate the ureter for subsequent endoscopic treatment.

Urologists or interventional radiologists can place a percutaneous nephrostomy tube if ureteral stenting is not possible. Usually, ultrasonography is used first to locate the dilated collecting system. Using the Seldinger technique, a tube ranging from 8-12F can be placed. Nephrostomies are typically placed when a retrograde stent cannot be passed because of anatomic changes in the bladder or high-grade obstruction in the ureter. Because this procedure can be performed under local anesthesia, patients who are too hemodynamically unstable for general anesthesia may undergo percutaneous nephrostomy tube placement. In addition, nephrostomy tube placement may be performed with minimal use of radiation and may be useful in pregnant patients.

Advances in endoscopic and percutaneous instrumentation have decreased the role of open or laparoscopic surgery for hydronephrosis. Certain causes of hydronephrosis, mostly extrinsic, still require treatment with open surgery. Examples include retroperitoneal fibrosis, retroperitoneal tumors, and aortic aneurysms. Some stones that cannot be treated endoscopically or with extracorporeal shockwave lithotripsy require open removal. Although endoscopic management does play a role in low-grade low-stage ureteral tumors, these lesions also usually require open or laparoscopic surgical management.

Urine should be collected from the kidney when obstruction is relieved to allow identification and targeted treatment of any infection that may be present.

Fetal surgery

Although several prospective and retrospective studies have examined antenatal surgery in fetuses with sonographic findings consistent with lower urinary tract obstruction, no good evidence supports that this intervention improves renal outcome.[36] Although these procedures may increase the amount of amniotic fluid, thus potentially improving lung development and survival rate, the rate of chronic renal disease is high in survivors, necessitating renal replacement therapy in almost two thirds of the cases.

The benefit of vesicoamniotic shunting (VAS) proved inconclusive in the Percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstruction (PLUTO) trial, which compared VAS with conservative nonsurgical management in 31 singleton fetuses younger than 28 weeks’ gestation with isolated bladder outflow obstruction. Although survival to 28 days and 1 year appeared to be higher with VAS than with conservative management, the PLUTO investigators could not prove benefit beyond reasonable doubt, and VAS was substantially more costly.[37]

Newborns in the PLUTO trial had a very low chance of surviving with normal renal function, regardless of whether they underwent VAS. Short-term and long-term morbidity in both trial groups was substantial, and complications of VAS resulted in pregnancy loss in some cases.[37]



Refer the patient to a urologist whenever hydronephrosis or hydroureter is newly diagnosed. Further consultations may be sought by the urologist, depending on the circumstances. For example, a nephrologist's input would be useful in cases of severe pathological postobstructive diuresis. In addition, an interventional radiologist would be needed for nephrostomy tube placement if urgent decompression is needed and ureteral stent placement is not possible. Patients with antenatal and postnatal hydronephrosis should be referred to a pediatric urologist for evaluation and management.

Contributor Information and Disclosures

Dennis G Lusaya, MD Associate Professor II, Department of Surgery (Urology), University of Santo Tomas; Head of Urology Unit, Benavides Cancer Institute, University of Santo Tomas Hospital; Chief of Urologic Oncology, St Luke’s Medical Center Global City, Philippines

Dennis G Lusaya, MD is a member of the following medical societies: American Urological Association, Philippine Medical Association, Philippine College of Surgeons, Philippine Urological Association, Philippine Society of Urological Oncology

Disclosure: Nothing to disclose.


Edgar V Lerma, MD, FACP, FASN, FAHA, FASH, FNLA, FNKF Clinical Professor of Medicine, Section of Nephrology, Department of Medicine, University of Illinois at Chicago College of Medicine; Research Director, Internal Medicine Training Program, Advocate Christ Medical Center; Consulting Staff, Associates in Nephrology, SC

Edgar V Lerma, MD, FACP, FASN, FAHA, FASH, FNLA, FNKF is a member of the following medical societies: American Heart Association, American Medical Association, American Society of Hypertension, American Society of Nephrology, Chicago Medical Society, Illinois State Medical Society, National Kidney Foundation, Society of General Internal Medicine

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Otsuka, Mallinckrodt, ZS Pharma<br/>Author for: UpToDate, ACP Smart Medicine.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Bradley Fields Schwartz, DO, FACS Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, Society of Laparoendoscopic Surgeons, Society of University Urologists, Association of Military Osteopathic Physicians and Surgeons, American Urological Association, Endourological Society

Disclosure: Nothing to disclose.

Additional Contributors

Richard A Santucci, MD, FACS Specialist-in-Chief, Department of Urology, Detroit Medical Center; Chief of Urology, Detroit Receiving Hospital; Director, The Center for Urologic Reconstruction; Clinical Professor of Urology, Michigan State University College of Medicine

Richard A Santucci, MD, FACS is a member of the following medical societies: American College of Surgeons, Societe Internationale d'Urologie (International Society of Urology), American Urological Association

Disclosure: Nothing to disclose.


The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Srinivas Vourganti, MD, Prakash Maniam, MD, and martin I Resnick, MD, to the development and writing of this article.

  1. Rose BD, Black RM. Manual of Clinical Problems in Nephrology. Boston, Mass: Little, Brown & Co; 1988. 337-343.

  2. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005 Jan 29-Feb 4. 365(9457):417-30. [Medline].

  3. Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: a literature survey. Eur J Obstet Gynecol Reprod Biol. 1988 Mar. 27(3):249-59. [Medline].

  4. Pain VM, Strandhoy JW, Assimis, DG. Pathophysiology of urinary tract obstruction. Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein AJ, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2007. Vol 2: 1227-73.

  5. Weidmann P, Beretta-Piccoli C, Hirsch D, Reubi FC, Massry SG. Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin. Ann Intern Med. 1977 Oct. 87(4):437-40. [Medline].

  6. Vaughan ED Jr, Bühler FR, Laragh JH. Normal renin secretion in hypertensive patients with primarily unilateral chronic hydronephrosis. J Urol. 1974 Aug. 112(2):153-6. [Medline].

  7. Josephson S. Antenatally detected pelvi-ureteric junction obstruction: concerns about conservative management. BJU Int. 2000 May. 85(7):973. [Medline].

  8. Platt JF, Rubin JM, Ellis JH. Acute renal obstruction: evaluation with intrarenal duplex Doppler and conventional US. Radiology. 1993 Mar. 186(3):685-8. [Medline].

  9. Demko TM, Diamond JR, Groff J. Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. J Am Soc Nephrol. 1997 Apr. 8(4):684-8. [Medline].

  10. Klahr S. Pathophysiology of obstructive nephropathy. Kidney Int. 1983 Feb. 23(2):414-26. [Medline].

  11. Sternberg KM, Pais VM Jr, Larson T, Han J, Hernandez N, Eisner B. Is hydronephrosis on ultrasound predictive of ureterolithiasis in patients with renal colic?. J Urol. 2016 May 3. [Medline].

  12. Webb JA. Ultrasonography in the diagnosis of renal obstruction. BMJ. 1990 Oct 27. 301(6758):944-6. [Medline]. [Full Text].

  13. Thoeny HC, Binser T, Roth B, Kessler TM, Vermathen P. Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: a prospective study. Radiology. 2009 Sep. 252(3):721-8. [Medline].

  14. Lupton EW, Testa HJ. The obstructive diuresis renogram: an appraisal of the significance. J Urol. 1992 Apr. 147(4):981-3. [Medline].

  15. Persutte WH, Hussey M, Chyu J, Hobbins JC. Striking findings concerning the variability in the measurement of the fetal renal collecting system. Ultrasound Obstet Gynecol. 2000 Mar. 15(3):186-90. [Medline].

  16. Robinson JN, Tice K, Kolm P, Abuhamad AZ. Effect of maternal hydration on fetal renal pyelectasis. Obstet Gynecol. 1998 Jul. 92(1):137-41. [Medline].

  17. Woodward M, Frank D. Postnatal management of antenatal hydronephrosis. BJU Int. 2002 Jan. 89(2):149-56. [Medline].

  18. Chung S, Majd M, Rushton HG, Belman AB. Diuretic renography in the evaluation of neonatal hydronephrosis: is it reliable?. J Urol. 1993 Aug. 150(2 Pt 2):765-8. [Medline].

  19. Taylor A Jr, Clark S, Ball T. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates. Clin Nucl Med. 1994 Jul. 19(7):575-80. [Medline].

  20. Gordon I. Diuretic renography in infants with prenatal unilateral hydronephrosis: an explanation for the controversy about poor drainage. BJU Int. 2001 Apr. 87(6):551-5. [Medline].

  21. Koff SA. Postnatal management of antenatal hydronephrosis using an observational approach. Urology. 2000 May. 55(5):609-11. [Medline].

  22. Gordon I, Dhillon HK, Gatanash H, Peters AM. Antenatal diagnosis of pelvic hydronephrosis: assessment of renal function and drainage as a guide to management. J Nucl Med. 1991 Sep. 32(9):1649-54. [Medline].

  23. Acker MR, Clark R, Anderson P. Gravity-assisted drainage imaging in the assessment of pediatric hydronephrosis. Can Urol Assoc J. 2016 Mar-Apr. 10 (3-4):96-100. [Medline]. [Full Text].

  24. Kim DY, Mickelson JJ, Helfand BT, Maizels M, Kaplan WE, Yerkes EB. Fetal pyelectasis as predictor of decreased differential renal function. J Urol. 2009 Oct. 182(4 Suppl):1849-53. [Medline].

  25. de Bruyn R, Marks SD. Postnatal investigation of fetal renal disease. Semin Fetal Neonatal Med. 2008 Jun. 13(3):133-41. [Medline].

  26. Grattan-Smith JD, Little SB, Jones RA. MR urography evaluation of obstructive uropathy. Pediatr Radiol. 2008 Jan. 38 Suppl 1:S49-69. [Medline].

  27. Mamì C, Paolata A, Palmara A, et al. Outcome and management of isolated moderate renal pelvis dilatation detected at postnatal screening. Pediatr Nephrol. 2009 Oct. 24(10):2005-8. [Medline].

  28. Dacher JN, Mandell J, Lebowitz RL. Urinary tract infection in infants in spite of prenatal diagnosis of hydronephrosis. Pediatr Radiol. 1992. 22(6):401-4; discussion 404-5. [Medline].

  29. Walsh TJ, Hsieh S, Grady R, Mueller BA. Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the first year of life. Urology. 2007 May. 69(5):970-4. [Medline].

  30. Coelho GM, Bouzada MC, Lemos GS, Pereira AK, Lima BP, Oliveira EA. Risk factors for urinary tract infection in children with prenatal renal pelvic dilatation. J Urol. 2008 Jan. 179(1):284-9. [Medline].

  31. Estrada CR, Peters CA, Retik AB, Nguyen HT. Vesicoureteral reflux and urinary tract infection in children with a history of prenatal hydronephrosis--should voiding cystourethrography be performed in cases of postnatally persistent grade II hydronephrosis?. J Urol. 2009 Feb. 181(2):801-6; discussion 806-7. [Medline].

  32. Lidefelt KJ, Herthelius M. Antenatal hydronephrosis: infants with minor postnatal dilatation do not need prophylaxis. Pediatr Nephrol. 2008 Nov. 23(11):2021-4. [Medline].

  33. Zareba P, Lorenzo AJ, Braga LH. Risk factors for febrile urinary tract infection in infants with prenatal hydronephrosis: comprehensive single center analysis. J Urol. 2014 May. 191(5 Suppl):1614-8. [Medline].

  34. Braga LH, Mijovic H, Farrokhyar F, Pemberton J, DeMaria J, Lorenzo AJ. Antibiotic prophylaxis for urinary tract infections in antenatal hydronephrosis. Pediatrics. 2013 Jan. 131(1):e251-61. [Medline].

  35. Herz D, Merguerian P, McQuiston L. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicoureteral reflux, or ureterovesical junction obstruction. J Pediatr Urol. 2014 Jul 22. [Medline].

  36. Coplen DE. Prenatal intervention for hydronephrosis. J Urol. 1997 Jun. 157(6):2270-7. [Medline].

  37. Morris RK, Malin GL, Quinlan-Jones E, Middleton LJ, Hemming K, Burke D, et al. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet. 2013 Nov 2. 382(9903):1496-506. [Medline]. [Full Text].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.